Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
Abstract Background The prostate-specific antigen (PSA) -value is often used during the prostate cancer trajectory as a marker of progression or response to treatment. Concerns about PSA-values are often expressed by patients in clinical situations. Today there is a lack of larger studies that have...
Main Authors: | Ulrika Rönningås, Per Fransson, Maja Holm, Agneta Wennman-Larsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12894-019-0493-1 |
Similar Items
-
Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01) -
Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01) -
PSA screening for prostate cancer
by: Marcus V. Sadi -
Controversies in Prostate Cancer Screening: is the Prostate Specific Antigen useful?
by: Pablo Yago Giménez, et al.
Published: (2019-12-01) -
Beyond prostate-specific antigen: alternatives for prostate neoplasm screening
by: Yu, Kevin Kuo-Han
Published: (2016)